Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Medical Countermeasures WHO Launches Clinical Trial of Two Experimental Ebola Treatments in DRCGlobal Biodefense StaffJune 25, 2026
Medical Countermeasures Experimental Two-in-One Vaccine Shows Early Promise Against Lassa Fever and RabiesGlobal Biodefense StaffJune 19, 2026
Novartis to Start Large, Randomized Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients Medical Countermeasures April 20, 2020 …
Investigational Chimp Adenovirus MERS-CoV Vaccine Protects Monkeys Medical Countermeasures April 17, 2020 …
Antiviral Remdesivir Prevents Disease Progression in Monkeys with COVID-19 Medical Countermeasures April 17, 2020 …
New Universal Ebola Vaccine May Fight All Four Virus Species that Infect Humans Medical Countermeasures April 16, 2020 …
Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets Industry News April 15, 2020 …
Inside the Effort to Repurpose a Manufacturing Platform to Produce COVID-19 Vaccines Medical Countermeasures April 15, 2020 …
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients Industry News April 14, 2020 …
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19 Industry News April 14, 2020 …
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19 Industry News April 14, 2020 …
BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections Industry News April 13, 2020 …
FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19 Medical Countermeasures April 7, 2020 …
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate Medical Countermeasures April 7, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19 Medical Countermeasures April 2, 2020 …
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19 Medical Countermeasures April 2, 2020 …
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy Medical Countermeasures April 2, 2020 …
